普瑞眼科
(301239)
| 流通市值：50.21亿 | | | 总市值：52.89亿 |
| 流通股本：1.42亿 | | | 总股本：1.50亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 2,445,941,857.05 | 1,602,037,256.53 | 820,353,329.11 | 2,797,261,037.47 |
| 营业总成本 | 2,215,728,155.61 | 1,464,529,396.87 | 726,043,058.39 | 2,746,109,913.2 |
| 其他经营收益 | | | | |
| 营业利润 | 235,327,569.95 | 138,822,349.8 | 94,247,163.12 | 31,074,382.72 |
| 利润总额 | 222,465,994.38 | 130,763,927.74 | 92,488,069.46 | 12,515,625.08 |
| 净利润 | 158,832,706.72 | 92,350,606.99 | 72,997,490.46 | -53,718,830.86 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | 29,078.28 |
| 综合收益总额 | 158,832,706.72 | 92,350,606.99 | 72,997,490.46 | -53,689,752.58 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 1,019,572,436.06 | 1,007,025,908.19 | 1,044,311,998.75 | 857,884,517.45 |
| 非流动资产: | | | | |
| 非流动资产合计 | 3,726,376,536.37 | 3,763,834,086.35 | 3,699,425,211.57 | 3,697,889,913.38 |
| 资产总计 | 4,745,948,972.43 | 4,770,859,994.54 | 4,743,737,210.32 | 4,555,774,430.83 |
| 流动负债: | | | | |
| 流动负债合计 | 1,036,775,085.56 | 1,013,989,397.64 | 898,768,576.15 | 866,133,976.92 |
| 非流动负债: | | | | |
| 非流动负债合计 | 1,529,215,406.85 | 1,589,305,629.74 | 1,696,756,783.54 | 1,622,679,017.34 |
| 负债合计 | 2,565,990,492.41 | 2,603,295,027.38 | 2,595,525,359.69 | 2,488,812,994.26 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 2,148,342,566.32 | 2,130,049,573.64 | 2,112,586,113.46 | 2,041,940,785.1 |
| 股东权益合计 | 2,179,958,480.02 | 2,167,564,967.16 | 2,148,211,850.63 | 2,066,961,436.57 |
| 负债和股东权益合计 | 4,745,948,972.43 | 4,770,859,994.54 | 4,743,737,210.32 | 4,555,774,430.83 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 2,471,528,003.51 | 1,616,665,046.19 | 825,078,545.4 | 2,842,689,394.07 |
| 经营活动现金流出小计 | 1,931,747,585.38 | 1,283,845,582.09 | 647,590,409.87 | 2,297,831,257.26 |
| 经营活动产生的现金流量净额 | 539,780,418.13 | 332,819,464.1 | 177,488,135.53 | 544,858,136.81 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 177,744,533.87 | 91,066,763.61 | 90,961,521.61 | 444,360,875.17 |
| 投资活动现金流出小计 | 449,170,585.86 | 300,983,048.1 | 188,397,441.1 | 891,553,570.34 |
| 投资活动产生的现金流量净额 | -271,426,051.99 | -209,916,284.49 | -97,435,919.49 | -447,192,695.17 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 141,741,875 | 133,741,875 | 133,741,875 | 206,179,984 |
| 筹资活动现金流出小计 | 276,253,232.76 | 148,124,078.8 | 66,909,781.29 | 445,584,575.42 |
| 筹资活动产生的现金流量净额 | -134,511,357.76 | -14,382,203.8 | 66,832,093.71 | -239,404,591.42 |
| 汇率变动对现金及现金等价物的影响 | -145,602.65 | -145,602.65 | - | 19,625.83 |
| 现金及现金等价物净增加额 | 133,697,405.73 | 108,375,373.16 | 146,884,309.75 | -141,719,523.95 |
| 期末现金及现金等价物余额 | 471,924,484.98 | 446,602,452.41 | 485,111,389 | 338,227,079.25 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | 108,375,373.16 | - | -141,719,523.95 |
最新报告期：2026-10-29| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 华创证券 | 郑辰,王宏雨 | 0.69 | 1.25 | 1.76 | 2026-10-29 |